Radiation-induced pulmonary toxicity and related risk factors in breast cancer

Journal of Breast Cancer

Volumn 12, Issue 2, 2009, Pages 67-72

  Hak, Jae Kim ^a,c   Won, Il Jang ^a   Tae, Jung Kim ^a   Jee, Hyun Kim ^a   Sung, Won Kim ^a   Sung, Ho Moon ^b   Jae, Sung Kim ^a   In, Ah Kim ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Dose volume histogram parameter; Pneumonitis; Radiotherapy; Risk factors

Indexed keywords

DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INCIDENCE; LUNG TOXICITY; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PHOTON; RADIATION DOSE; RADIATION INJURY; RADIATION PNEUMONIA;

EID: 71049144790     PISSN: 17386756     EISSN: None     Source Type: Journal    
DOI: 10.4048/jbc.2009.12.2.67     Document Type: Article

References (21)

1. McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable end point, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-1203
2. Rosai J. acute pulmonary injury and interstitial pneumonia. In: Rosai J, editor. Ackerman's surgical pathology. Vol.1, 8th ed. New York: Mosby; 1996. p.358-359
3. Gross NJ. Experimental radiation pneumonitis. IV. Leakage of circulatory proteins onto the alveolar surface. J Lab Clin Med 1980;95:19-31.
4. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, Das SK, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-659 (Pubitemid 32946899)
5. Armstrong JG, Zelefsky MJ, Leibel SA, Burman C, Han C, Harrison LB, et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 1995;6:693-697
6. Kim TH, Cho KH, Pyo HR, Lee JS, Zo JI, Lee DH, et al. Dose-volumetric parameters predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235:208-215 (Pubitemid 40432256)
7. Movsas B, Raffin TA, Epstein AH, Link CJ. Pulmonary radiation injury. Chest 1997;111:1061-1076
8. Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR. Radiation pneumonitis in breast cancer treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991;21:355-360
9. Lind PARM, Gagliardi G, Wennberg B, Fornander T. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997;36:509-515 (Pubitemid 27372145)
10. Bentzen SM, Skoczylas JZ, Overgaard M, Overgaard J. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst 1996;88:918-922 (Pubitemid 26230643)
11. Theuws JC, Kwa SL, Wagenaar AC, Boersma LJ, Damen EM, Muller SH, et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 1998;48:33-43.
12. Lind PA, Marks LB, Jamieson TA, Carter DL, Vredenburgh JJ, Folz RL, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose CTx and stem-cell rescue. Cancer 2002;94:2821-2829
13. Quon H, shepherd FA, Payne DG, Coy P, Murray N, Feld R, et al. The influence of age on delivery, tolerance, and efficacy of thoracic irradiatin in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999;43:39-45. (Pubitemid 29065830)
14. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806-1811 (Pubitemid 33150453)
15. Burstein HJ, Bellon JR, Galper S, Lu HM, Kuter I, Taghian AG, et al. Prospective evaluation of concurrent paclitaxel and radiation therapy after adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys 2006;64:496-504. (Pubitemid 43083438)
16. Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys 2005;62:386-391
17. Yu TK, Whitman GJ, Thames HD, Buzdar AU, Strom EA, Perkins GH, et al. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiation in breast cancer patients. J Natl Cancer Inst 2004;96:1676-1681
18. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-329 (Pubitemid 29408545)
19. Kim KJ, Suh CO. Partial breast cancer (PBI). J Korean Breast Cancer Soc 2004:7:65-71.
20. Voduc KD, Tyldesley S, Chia S. Risk of radiation pneumonitis in breast cancer patients treated with adjuvant taxanes and radiation. 2004 ASCO Annual Meeting. 2004;22. abstract #624.
21. Hanna YM, Baglan KL, Stromgber JS, Vicini FA, Decker DA. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 2002;8:149-153 (Pubitemid 34627772)